TeselaGen Biotechnology operates in the synthetic biology market, providing an AI-driven platform that facilitates the design, construction, and testing of biological systems. The company serves biotechnology firms, research institutions, and pharmaceutical companies. TeselaGen's business model revolves around a subscription-based Software as a Service (SaaS) offering, generating revenue through user subscriptions and licensing fees. The platform integrates various modules—DESIGN, BUILD, and TEST—that streamline the entire synthetic biology workflow, enhancing efficiency and reducing time to market for biotechnological innovations. By leveraging machine learning and automation, TeselaGen helps clients accelerate research and development processes, ultimately leading to faster and more cost-effective production of biological products.

Keywords: AI-driven, synthetic biology, SaaS, biotechnology, research institutions, pharmaceutical, design, build, test, automation.